Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Accelerating translational research by clinically driven development of an informatics platform-a case study.

Abugessaisa I, Saevarsdottir S, Tsipras G, Lindblad S, Sandin C, Nikamo P, Ståhle M, Malmström V, Klareskog L, Tegnér J.

PLoS One. 2014 Sep 9;9(9):e104382. doi: 10.1371/journal.pone.0104382. eCollection 2014.

PMID:
25203647
[PubMed - in process]
Free PMC Article
2.

Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.

Snir O, Gomez-Cabrero D, Montes A, Perez-Pampin E, Gómez-Reino JJ, Seddighzadeh M, Klich KU, Israelsson L, Ding B, Catrina AI, Holmdahl R, Alfredsson L, Klareskog L, Tegnér J, Gonzalez A, Malmström V, Padyukov L.

Arthritis Res Ther. 2014 Aug 20;16(5):414. [Epub ahead of print]

PMID:
25138370
[PubMed - as supplied by publisher]
3.

Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.

Ossipova E, Cerqueira CF, Reed E, Kharlamova N, Israelsson L, Holmdahl R, Nandakumar KS, Engström M, Harre U, Schett G, Catrina AI, Malmström V, Sommarin Y, Klareskog L, Jakobsson PJ, Lundberg K.

Arthritis Res Ther. 2014 Aug 12;16(4):R167. [Epub ahead of print]

PMID:
25112157
[PubMed - as supplied by publisher]
4.

Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis.

Catrina AI, Ytterberg AJ, Reynisdottir G, Malmström V, Klareskog L.

Nat Rev Rheumatol. 2014 Jul 29. doi: 10.1038/nrrheum.2014.115. [Epub ahead of print] Review.

PMID:
25072264
[PubMed - as supplied by publisher]
5.

Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice.

Lindh I, Snir O, Lönnblom E, Uysal H, Andersson I, Nandakumar KS, Vierboom M, 't Hart B, Malmström V, Holmdahl R.

Arthritis Res Ther. 2014 Jul 8;16(4):R143. doi: 10.1186/ar4605.

PMID:
25005029
[PubMed - in process]
6.

Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion.

Herrath J, Chemin K, Albrecht I, Catrina AI, Malmström V.

Eur J Immunol. 2014 Jul 2. doi: 10.1002/eji.201344140. [Epub ahead of print]

PMID:
24990235
[PubMed - as supplied by publisher]
7.

Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.

Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, Haj Hensvold A, Eklund A, Sköld CM, Grunewald J, Malmström V, Jakobsson PJ, Rönnelid J, Padyukov L, Zubarev RA, Klareskog L, Catrina AI.

Ann Rheum Dis. 2014 May 9. doi: 10.1136/annrheumdis-2013-204912. [Epub ahead of print]

PMID:
24817415
[PubMed - as supplied by publisher]
8.

Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.

Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, Malmström V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D.

Ann Rheum Dis. 2014 Oct;73(10):1761-8. doi: 10.1136/annrheumdis-2013-205109. Epub 2014 May 8.

PMID:
24812286
[PubMed - in process]
9.

Autoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritis.

Holmdahl R, Malmström V, Burkhardt H.

Eur J Immunol. 2014 Jun;44(6):1593-9. doi: 10.1002/eji.201444486. Epub 2014 May 3. Review.

PMID:
24737176
[PubMed - indexed for MEDLINE]
10.

Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult.

Fiskesund R, Steen J, Amara K, Murray F, Szwajda A, Liu A, Douagi I, Malmström V, Frostegård J.

J Immunol. 2014 May 15;192(10):4551-9. doi: 10.4049/jimmunol.1303035. Epub 2014 Apr 11.

PMID:
24729615
[PubMed - indexed for MEDLINE]
11.

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Nielsen N, Pascal V, Fasth AE, Sundström Y, Galsgaard ED, Ahern D, Andersen M, Baslund B, Bartels EM, Bliddal H, Feldmann M, Malmström V, Berg L, Spee P, Söderström K.

Immunology. 2014 Aug;142(4):581-93. doi: 10.1111/imm.12271.

PMID:
24673109
[PubMed - indexed for MEDLINE]
12.

Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy.

James EA, Rieck M, Pieper J, Gebe JA, Yue BB, Tatum M, Peda M, Sandin C, Klareskog L, Malmström V, Buckner JH.

Arthritis Rheumatol. 2014 Jul;66(7):1712-22. doi: 10.1002/art.38637.

PMID:
24665079
[PubMed - indexed for MEDLINE]
13.

An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-β yields a dominant immunosuppressive phenotype.

Mia S, Warnecke A, Zhang XM, Malmström V, Harris RA.

Scand J Immunol. 2014 May;79(5):305-14. doi: 10.1111/sji.12162.

PMID:
24521472
[PubMed - indexed for MEDLINE]
14.

Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.

Pieper J, Johansson S, Snir O, Linton L, Rieck M, Buckner JH, Winqvist O, van Vollenhoven R, Malmström V.

Scand J Immunol. 2014 Feb;79(2):149-55. doi: 10.1111/sji.12139.

PMID:
24313359
[PubMed - indexed for MEDLINE]
15.

Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins.

Haj Hensvold A, Magnusson PK, Joshua V, Hansson M, Israelsson L, Ferreira R, Jakobsson PJ, Holmdahl R, Hammarström L, Malmström V, Askling J, Klareskog L, Catrina AI.

Ann Rheum Dis. 2013 Nov 25. doi: 10.1136/annrheumdis-2013-203947. [Epub ahead of print]

PMID:
24276366
[PubMed - as supplied by publisher]
16.

Adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis.

Klareskog L, Amara K, Malmström V.

Curr Opin Rheumatol. 2014 Jan;26(1):72-9. doi: 10.1097/BOR.0000000000000016. Review.

PMID:
24257366
[PubMed - indexed for MEDLINE]
17.

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.

Pieper J, Herrath J, Raghavan S, Muhammad K, Vollenhoven Rv, Malmström V.

BMC Immunol. 2013 Aug 5;14:34. doi: 10.1186/1471-2172-14-34.

PMID:
23915385
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Autoimmunity in rheumatoid arthritis: citrulline immunity and beyond.

Klareskog L, Lundberg K, Malmström V.

Adv Immunol. 2013;118:129-58. doi: 10.1016/B978-0-12-407708-9.00003-0.

PMID:
23683943
[PubMed - indexed for MEDLINE]
19.

Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up.

Zong M, Dorph C, Dastmalchi M, Alexanderson H, Pieper J, Amoudruz P, Barbasso Helmers S, Nennesmo I, Malmström V, Lundberg IE.

Ann Rheum Dis. 2014 May;73(5):913-20. doi: 10.1136/annrheumdis-2012-202857. Epub 2013 Apr 26.

PMID:
23625983
[PubMed - indexed for MEDLINE]
20.

Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.

Strollo R, Ponchel F, Malmström V, Rizzo P, Bombardieri M, Wenham CY, Landy R, Perret D, Watt F, Corrigall VM, Winyard PG, Pozzilli P, Conaghan PG, Panayi GS, Klareskog L, Emery P, Nissim A.

Arthritis Rheum. 2013 Jul;65(7):1702-12. doi: 10.1002/art.37964.

PMID:
23575908
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk